You are here

Correvio

FDA makes it official, once again rejecting battered Correvio’s heart drug

Endpoints

Mon, 12/30/19 - 09:55 am

complete response letter

atrial fibrillation

Deserted by Astellas and Merck, little Correvio still can't win over FDA panel concerned with its AFib drug's safety

Endpoints

Wed, 12/11/19 - 10:29 am

clinical trials

atrial fibrillation

Correvio slumps after FDA staffers say benefits of heart drug do not outweigh risks

Reuters

Fri, 12/6/19 - 09:32 pm

atrial fibrillation